{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:19:50Z","timestamp":1794374390818,"version":"4.9.0"},"reference-count":21,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["GR-2018-12365982"],"award-info":[{"award-number":["GR-2018-12365982"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ESPEN research fellowship"},{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["FISM 2018\/S\/5"],"award-info":[{"award-number":["FISM 2018\/S\/5"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["2020\/R\/13"],"award-info":[{"award-number":["2020\/R\/13"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Progetti di Rilevante Interesse Nazionale","award":["2017 K55HLC 001)"],"award-info":[{"award-number":["2017 K55HLC 001)"]}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2019-12371111"],"award-info":[{"award-number":["RF-2019-12371111"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Novo Nordisk Programme for Diabetes Research in Europe 2020"},{"name":"Progetti di Rilevante Interesse Nazionale","award":["2020 202077EYN7"],"award-info":[{"award-number":["2020 202077EYN7"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Poor glucose control has been associated with increased mortality in COVID-19 patients with type 1 diabetes (T1D).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This work aimed to assess the effect of prevaccination glucose control on antibody response to the SARS-CoV-2 vaccine BNT162b2 in T1D.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We studied 26 patients with T1D scheduled to receive 2 doses, 21 days apart, of BNT162b2, followed prospectively for 6 months with regular evaluation of SARS-CoV-2 antibodies and glucose control. Immunoglobulin G (IgG) to spike glycoprotein were assessed by enzyme-linked immunosorbent assay, and serum neutralization by a live SARS-CoV-2 assay (Vero E6 cells system). Glycated hemoglobin A1c (HbA1c) and continuous glucose monitoring (CGM), including time in range (TIR) and above range (TAR), were collected. The primary exposure and outcome measures were prevaccination glucose control, and antibody response after vaccination, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Prevaccination HbA1c was unrelated to postvaccine spike IgG (r = \u22120.33; P = .14). Of note, the CGM profile collected during the 2 weeks preceding BNT162b2 administration correlated with postvaccine IgG response (TIR: r = 0.75; P = .02; TAR: r = \u22120.81; P = .008). Patients meeting the recommended prevaccination glucose targets of TIR (\u2265 70%) and TAR (\u2264 25%) developed stronger neutralizing antibody titers (P &amp;lt; .0001 and P = .008, respectively), regardless of HbA1c. Glucose control along the study time frame was also associated with IgG response during follow-up (TIR: r = 0.93; P &amp;lt; .0001; TAR: r = \u22120.84; P &amp;lt; .0001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In T1D, glucose profile during the 2 weeks preceding vaccination is associated with stronger spike antibody binding and neutralization, highlighting a role for well-controlled blood glucose in vaccination efficacy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgad001","type":"journal-article","created":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T04:48:11Z","timestamp":1673153291000},"page":"e474-e479","source":"Crossref","is-referenced-by-count":6,"title":["Prevaccination Glucose Time in Range Correlates With Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes"],"prefix":"10.1210","volume":"108","author":[{"given":"Ghadeer","family":"Alhamar","sequence":"first","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"},{"name":"Dasman Diabetes Institute , 15462 Kuwait City , Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Briganti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Maggi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4557-816X","authenticated-orcid":false,"given":"Viola","family":"Viola","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Faraj","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Zannella","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Sperimentale, Universit\u00e0 degli Studi della Campania \u201cLuigi Vanvitelli,\u201d 80138 Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Galdiero","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Sperimentale, Universit\u00e0 degli Studi della Campania \u201cLuigi Vanvitelli,\u201d 80138 Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Franci","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Chirurgia ed Odontoiatria \u201cScuola Medica Salernitana,\u201d Universit\u00e0 degli Studi di Salerno , 84081 Baronissi , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clorinda","family":"Fusco","sequence":"additional","affiliation":[{"name":"Istituto per l\u2019Endocrinologia e l\u2019Oncologia Sperimentale \u201cG. Salvatore,\u201d Consiglio Nazionale delle Ricerche , 80131 Naples , Italy"},{"name":"Unit\u00e0 di Neuroimmunologia, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Santa Lucia , 00179 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Isgr\u00f2","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"},{"name":"Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari \u201cAldo Moro,\u201d 70121 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Leanza","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Malandrucco","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa Semplice Dipartimentale Endocrinologia e Malattie Metaboliche, Azienda Sanitaria Locale (ASL) Frosinone , 03100 Frosinone , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Spinelli","sequence":"additional","affiliation":[{"name":"Department of Science and Technology for Humans and the Environment, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Tramontana","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Iaria","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Tortoriello","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pieralice","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Rosati","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9429-0616","authenticated-orcid":false,"given":"Giuseppe","family":"Matarese","sequence":"additional","affiliation":[{"name":"Istituto per l\u2019Endocrinologia e l\u2019Oncologia Sperimentale \u201cG. Salvatore,\u201d Consiglio Nazionale delle Ricerche , 80131 Naples , Italy"},{"name":"Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 degli Studi di Napoli \u201cFederico II,\u201d 80131 Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pozzilli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology & Diabetes Unit, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Galgani","sequence":"additional","affiliation":[{"name":"Istituto per l\u2019Endocrinologia e l\u2019Oncologia Sperimentale \u201cG. Salvatore,\u201d Consiglio Nazionale delle Ricerche , 80131 Naples , Italy"},{"name":"Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 degli Studi di Napoli \u201cFederico II,\u201d 80131 Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8967-7613","authenticated-orcid":false,"given":"Rocky","family":"Strollo","sequence":"additional","affiliation":[{"name":"Department of Science and Technology for Humans and the Environment, Universit\u00e0 Campus Bio-Medico di Roma , 00128 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"issue":"10","key":"2024012422154785500_dgad001-B1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2024012422154785500_dgad001-B2","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"10","key":"2024012422154785500_dgad001-B3","doi-asserted-by":"crossref","first-page":"e3990","DOI":"10.1210\/clinem\/dgac459","article-title":"The importance of continuous glucose monitoring-derived metrics beyond HbA1c for optimal individualized glycemic control","volume":"107","author":"Yoshii","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024012422154785500_dgad001-B4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"2024012422154785500_dgad001-B5","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1007\/s00125-015-3746-x","article-title":"Antibodies to post-translationally modified insulin in type 1 diabetes","volume":"58","author":"Strollo","year":"2015","journal-title":"Diabetologia"},{"issue":"7","key":"2024012422154785500_dgad001-B6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"2024012422154785500_dgad001-B7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00125-022-05812-4","article-title":"Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes","volume":"66","author":"Strollo","year":"2023","journal-title":"Diabetologia"},{"issue":"2","key":"2024012422154785500_dgad001-B8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/08916930802468276","article-title":"Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes","volume":"42","author":"Khan","year":"2009","journal-title":"Autoimmunity"},{"issue":"10","key":"2024012422154785500_dgad001-B9","doi-asserted-by":"crossref","first-page":"e0052721","DOI":"10.1128\/JCM.00527-21","article-title":"Evaluation of cell-based and surrogate SARS-CoV-2 neutralization assays","volume":"59","author":"Sholukh","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2024012422154785500_dgad001-B10","doi-asserted-by":"crossref","first-page":"103724","DOI":"10.1016\/j.msard.2022.103724","article-title":"Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod","volume":"60","author":"Capuano","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"2024012422154785500_dgad001-B11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/dom.14643","article-title":"Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: the prospective COVAC-DM cohort study","volume":"24","author":"Sourij","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"2024012422154785500_dgad001-B12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/vaccines10030382","article-title":"Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in people with diabetes: a prospective observational study","volume":"10","author":"Papadokostaki","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"2024012422154785500_dgad001-B13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/dom.14547","article-title":"Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: the CAVEAT study","volume":"24","author":"Marfella","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"2024012422154785500_dgad001-B14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/dia.2020.0501","article-title":"HbA1c and glucose management indicator discordance: a real-world analysis","volume":"23","author":"Perlman","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2024012422154785500_dgad001-B15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/pedi.13299","article-title":"Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes","volume":"23","author":"Piona","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"2024012422154785500_dgad001-B16","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1177\/19322968211026291","article-title":"Analysis of continuous blood glucose data in people with type 1 diabetes (T1DM) after COVID-19 vaccination indicates a possible link between the immune and the metabolic response","volume":"15","author":"Heald","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"2024012422154785500_dgad001-B17","doi-asserted-by":"crossref","first-page":"109022","DOI":"10.1016\/j.diabres.2021.109022","article-title":"Short-term safety profile of Sars-Cov2 vaccination on glucose control: continuous glucose monitoring data in people with autoimmune diabetes","volume":"179","author":"D\u2019Onofrio","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"2024012422154785500_dgad001-B18","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2337\/db22-0053","article-title":"Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes","volume":"71","author":"D\u2019Addio","year":"2022","journal-title":"Diabetes"},{"issue":"5","key":"2024012422154785500_dgad001-B19","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10067-022-06149-4","article-title":"Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune\/inflammatory syndrome expand?","volume":"41","author":"Jara","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2024012422154785500_dgad001-B20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41574-021-00608-9","article-title":"Metabolic disorders, COVID-19 and vaccine-breakthrough infections","volume":"18","author":"Stefan","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2024012422154785500_dgad001-B21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/590565","article-title":"Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells","volume":"47","author":"Restrepo","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad001\/48745572\/dgad001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/7\/e474\/56405515\/dgad001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/7\/e474\/56405515\/dgad001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T22:16:20Z","timestamp":1706134580000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/7\/e474\/6972436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,1,6]]},"published-print":{"date-parts":[[2023,6,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad001","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,1,6]]}}}